Listed

IGC Pharma, Inc.: Form 10-K for the period ended Mar 31, 2018

Filed with the SEC on Jun 21, 2018 and accepted by EDGAR at Jun 21, 2018, 17:18 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2017-04-01 to 2018-03-31$2.2mus-gaap:Revenues
Cost of revenue12 months2017-04-01 to 2018-03-31$2.1mus-gaap:CostOfRevenue
Gross profit12 months2017-04-01 to 2018-03-31$81.5kus-gaap:GrossProfit
Selling, general and administrative12 months2017-04-01 to 2018-03-31$1.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2017-04-01 to 2018-03-31−$1.8mus-gaap:OperatingIncomeLoss
Interest expense12 months2017-04-01 to 2018-03-31$30.7kus-gaap:InterestExpense
Income tax12 months2017-04-01 to 2018-03-31$464us-gaap:IncomeTaxExpenseBenefit
Net income12 months2017-04-01 to 2018-03-31−$1.8mus-gaap:NetIncomeLoss
Diluted EPS12 months2017-04-01 to 2018-03-31−$0.06us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2017-04-01 to 2018-03-31−$1.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2017-04-01 to 2018-03-31$135.7kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2018-03-31$1.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-03-31$3.2mus-gaap:AssetsCurrent
Total assetsAt period end2018-03-31$10.9mus-gaap:Assets
Current liabilitiesAt period end2018-03-31$2.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-03-31$2.8mus-gaap:Liabilities
Shareholders' equityAt period end2018-03-31$8.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001185185-18-001155. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.